Source: MarketScreener

Achillion: Achillion Pharmaceuticals : Ahold Delhaize share buyback update July 7, 2020

(marketscreener.com) Zaandam, the Netherlands, July 7, 2020 - Ahold Delhaize has repurchased 250,000 of Ahold Delhaize common shares in the period from June 29, 2020 up to and including July 3, 2020. The shares were repurchased at an average price of €24.07 per share for a total consideration of € 6.02 million. These repurchases were made as...https://www.marketscreener.com/ACHILLION-PHARMACEUTICALS-35614/news/Achillion-Pharmaceuticals-Ahold-Delhaize-share-buyback-update-July-7-2020-30885552/?utm_medium=RSS&utm_content=20200707

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Joseph Truitt's photo - President & CEO of Achillion Pharmaceuticals Inc

President & CEO

Joseph Truitt

CEO Approval Rating

87/100

Read more